Claims
- 1. An isolated nucleic acid molecule comprising a nucleotide sequence encoding a full length human wild type RB protein, as shown in FIG. 6.
- 2. The isolated nucleic acid molecule of claim 1, wherein the nucleotide sequence is as shown in FIG. 6.
- 3. An isolated nucleic acid vector suitable for transfecting mammalian cancer cells, the vector comprising transcription regulatory sequences operably linked to a nucleotide sequence encoding a full length human wild type RB protein, as shown in FIG. 6.
- 4. The vector of claim 3, wherein the nucleotide sequence is as shown in FIG. 6.
- 5. The vector of claim 3, which is a virus.
- 6. The vector of claim 3, which is complexed with a liposome.
CROSS REFERENCES TO RELATED APPLICATIONS
This application is a continuation of application Ser. No. 07/764,714, filed Sep. 24, 1991, (now abandoned) which is a continuation of U.S. Ser. No. 07/265,829 filed Oct. 31, 1988, (now abandoned); which is a continuation-in-part of U.S. Ser. No. 091,547 filed Aug. 31, 1987 (patent issued: U.S. Pat. No. 5,011,773); U.S. Ser. No. 098,612 filed Sep. 17, 1987 (patent issued: U.S. Pat. No. 4,942,123); and U.S. Ser. No. 108,748 filed Oct. 15, 1987 (abandoned).
Government Interests
This invention was made with Government support under Grant No. EY05758 with the National Institute of Health, and the University of California. The Government has certain rights in this invention.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4497796 |
Salser et al. |
Feb 1985 |
|
5532220 |
Lee et al. |
Jul 1996 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
WO 8906703 |
Jul 1989 |
WOX |
Related Publications (2)
|
Number |
Date |
Country |
|
98612 |
Sep 1987 |
|
|
108748 |
Oct 1987 |
|
Continuations (2)
|
Number |
Date |
Country |
Parent |
764714 |
Sep 1991 |
|
Parent |
265829 |
Oct 1988 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
91547 |
Aug 1987 |
|